Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot factorial study of Omacor and/or fluvastatin in chronic hepatitis C non-responders
2006-004335-29Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- May 2007
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of omega-3-acid triglycerides and fluvastatin in hepatitis C virus infection (4 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Fall in HCV viral load at end of treatment. Started May 2007; status: completed.
02
Drugs
omega-3-acid triglyceridesfluvastatin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-004335-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004335-29.